Premium Nahrungsergänzungsmittel | artgerecht

Follicle Stimulation Protocol – IVF Guide

A follicle stimulation protocol is a medical treatment plan used in assisted reproduction to stimulate the ovaries to produce multiple eggs for IVF or ICSI procedures.

Regular tips about health Regular tips about health

Things worth knowing about "Follicle Stimulation Protocol"

A follicle stimulation protocol is a medical treatment plan used in assisted reproduction to stimulate the ovaries to produce multiple eggs for IVF or ICSI procedures.

What is a Follicle Stimulation Protocol?

A follicle stimulation protocol is an individually tailored medical treatment plan used in assisted reproductive technology (ART), particularly in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). Its primary goal is to stimulate the ovaries using hormonal medications so that multiple egg follicles mature simultaneously, providing several eggs for retrieval and fertilisation.

Under natural conditions, only one egg typically matures per menstrual cycle. By administering gonadotropin hormones, a stimulation protocol enables the controlled development of multiple follicles, significantly improving the chances of a successful IVF treatment.

Types of Follicle Stimulation Protocols

There are several protocol types, each selected based on the patient´s individual profile, age, ovarian reserve, and the clinic´s approach:

Long Protocol (GnRH Agonist Protocol)

In the long protocol, the body´s own hormone production is first suppressed over several weeks using a GnRH agonist (e.g. buserelin, leuprorelin) – a process known as downregulation. Ovarian stimulation with FSH (follicle-stimulating hormone) and/or LH (luteinising hormone) then follows. This protocol offers excellent cycle control but requires a longer treatment period.

Short Protocol (GnRH Antagonist Protocol)

In the short protocol, ovarian stimulation begins directly from day two or three of the cycle. A GnRH antagonist (e.g. cetrorelix, ganirelix) is introduced later to prevent a premature LH surge and unintended ovulation. This approach is shorter in duration and is often preferred for women at higher risk of ovarian hyperstimulation syndrome (OHSS).

Mild Stimulation Protocol

The mild stimulation protocol uses lower doses of hormones to reduce the physical burden on the patient. It is frequently recommended for women with diminished ovarian reserve or those considered at higher risk for complications.

Course of Ovarian Stimulation

A typical follicle stimulation protocol follows these key stages:

Baseline assessment: Ultrasound examination and blood tests to measure hormone levels (FSH, LH, estradiol, AMH) and count antral follicles.
Stimulation phase: Daily subcutaneous injections of gonadotropins over 8 to 14 days to encourage multiple follicles to develop.
Monitoring: Regular ultrasound scans and blood tests to track follicle growth and hormone levels.
Triggering ovulation: Once follicles reach an adequate size (typically 17–20 mm), an hCG injection or GnRH agonist is administered to trigger final egg maturation.
Egg retrieval: Approximately 36 hours after the trigger injection, eggs are collected via a transvaginal ultrasound-guided puncture procedure.

Risks and Side Effects

Hormonal stimulation can cause side effects and potential complications, including:

Ovarian Hyperstimulation Syndrome (OHSS): An excessive ovarian response that can range from mild bloating and abdominal discomfort to severe complications such as fluid accumulation in the abdomen.
Local injection site reactions such as redness and swelling.
Mood swings, headaches, and fatigue caused by hormonal changes.
Multiple pregnancy when more than one embryo is transferred.

Importance and Success Rates

Selecting the appropriate stimulation protocol is critical to the outcome of IVF treatment. An individualised protocol based on age, hormonal profile, and ovarian reserve can optimise the number of eggs retrieved and minimise the risk of complications. Success rates vary considerably depending on age and individual clinical factors.

References

Diedrich K. et al. – Reproduktionsmedizin, Springer Verlag, 2013.
European Society of Human Reproduction and Embryology (ESHRE) – Ovarian Stimulation for IVF/ICSI: Guidelines, 2020. Available at: https://www.eshre.eu
Fauser B.C. et al. – Mild ovarian stimulation for IVF: 10 years later. Human Reproduction, 2010; 25(11):2678–2684. PubMed PMID: 20833739.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.